Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-clinical Participants”

196 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 196 results

Large-scale testing (Phase 3)Study completedNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 479
Large-scale testing (Phase 3)Looking for participantsNCT07555483
What this trial is testing

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha 1 Antitrypsin Deficiency
Grifols Therapeutics LLC 40
Large-scale testing (Phase 3)Not Yet RecruitingNCT07634471
What this trial is testing

A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)

Who this might be right for
Follicular Lymphoma
Merck Sharp & Dohme LLC 960
Large-scale testing (Phase 3)Looking for participantsNCT06754644
What this trial is testing

Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With IV nqNSCLC

Who this might be right for
NSCLC
Qilu Pharmaceutical Co., Ltd. 808
Testing effectiveness (Phase 2)Looking for participantsNCT06914128
What this trial is testing

PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Who this might be right for
MTAP-deleted Solid Tumors
Bayer 450
Early research (Phase 1)Ended earlyNCT04322253
What this trial is testing

Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose in Participants With Liver Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Pharmacology, Clinical
Bayer 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06626555
What this trial is testing

Clinical Trial to Evaluate the Effects of Letermovir Prophylaxis on T-cell Immune Activation in Participants With Treated HIV-1 Infection

Who this might be right for
HIV
University College, London 36
Post-approval studies (Phase 4)Study completedNCT03190330
What this trial is testing

Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Mantle-Cell
Johnson & Johnson Private Limited 75
Large-scale testing (Phase 3)Not Yet RecruitingNCT07028801
What this trial is testing

Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells)

Who this might be right for
Rabies
Ningbo Rongan Biological Pharmaceutical Co., Ltd. 3,000
Large-scale testing (Phase 3)WithdrawnNCT07551544
What this trial is testing

ANKTIVA Plus BCG Versus BCG Monotherapy In Participants With BCG-Naïve/BCG-Exposed High-Grade Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
NMIBC
ImmunityBio, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07221227
What this trial is testing

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,200
Large-scale testing (Phase 3)Looking for participantsNCT07582432
What this trial is testing

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Grifols Biologicals, LLC 49
Testing effectiveness (Phase 2)Looking for participantsNCT07249905
What this trial is testing

Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Who this might be right for
LymphomaWaldenström Macroglobulinemia (WM)DLBCL - Diffuse Large B Cell Lymphoma+5 more
ModeX Therapeutics, An OPKO Health Company 180
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)Looking for participantsNCT03666000
What this trial is testing

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
Non-Hodgkin LymphomaB-cell Acute Lymphoblastic LeukemiaChronic Lymphocytic Leukemia+1 more
Imugene Limited 135
Not applicableStudy completedNCT05444933
What this trial is testing

Collect Pre-existing Data on the Administration of Cabozantinib in Participants With Advanced Renal Cell Carcinoma (aRCC) Who Initiated Cabozantinib in 2nd Line in a Real-life Clinical Setting in France.

Who this might be right for
Advanced Renal Cell Carcinoma
Ipsen 252
Early research (Phase 1)Study completedNCT01088048
What this trial is testing

Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
Indolent Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma
Gilead Sciences 241
Not applicableLooking for participantsNCT07449234
What this trial is testing

Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag Ltd. 200
Large-scale testing (Phase 3)Study completedNCT04575597
What this trial is testing

Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

Who this might be right for
Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC 1,735
Not applicableStudy completedNCT06592911
What this trial is testing

Examining the Effect of a Digital MD for Cognitive and Musical Training + Reduced Conventional SOC on the Reading and Writing Skills of Pediatric Participants With a Specific Learning Disability With Reading and/or Written Expression Deficit vs a Control Group Receiving Conventional SOC.

Who this might be right for
Learning Disorder, SpecificLearning DisabilitySpecific Learning Disorder, With Impairment in Reading+1 more
Poppins 306
Load More Results